[Social inequalities in healthcare provision for patients with coronary heart disease: Results from the GEDA (German Health Update) study 2014/2015]

Z Evid Fortbild Qual Gesundhwes. 2021 Feb:160:48-54. doi: 10.1016/j.zefq.2020.11.009. Epub 2021 Jan 13.
[Article in German]

Abstract

Introduction: Little is known about social inequalities in outpatient long-term care of coronary heart disease (CHD) in Germany.

Methods: Regression analyses are based on the responses of women and men who participated in the national cross-sectional study "German Health update" (GEDA) 2014/2015 and had self-reported CHD (N=920). Outpatient healthcare of CHD was analysed on the basis of the self-reported administration of antihypertensive and cholesterol-lowering drugs, and the frequency of general practitioner (GP) contacts.

Results: On average, respondents visited their GP 7.5 times a year (mean). 46 % did not receive guideline-consistent treatment, i. e. both antihypertensive and cholesterol-lowering drugs. Respondents of lower social status consulted their GP more frequently (approx. two visits per year) than those of higher social status (AME: 1.94; 95% CI 0.56 to 3.31). Regarding treatment with antihypertensive and cholesterol-lowering drugs, there were no significant differences for either gender or social status. Nevertheless, the probability that respondents with increased levels of blood lipids or cholesterol took only one or none of the two medications recommended for long-term treatment of CHD was reduced by 54 percentage points (AME: -0,54; 95% CI -0,61 to -0,48).

Discussion: There are no social inequalities in the treatment of CHD patients with antihypertensive and cholesterol-lowering drugs, but inequalities exist in the frequency of visits to the GP who is more often consulted by the more socially disadvantaged patients.

Conclusion: With about 7.5 consultations per year, CHD patients visit their general practitioner more often than average, but in about half of these patients the medication supply is less than optimal. This may indicate a deficit in the medical treatment of CHD that cannot be explained by social inequalities. A possible starting point for improving healthcare, especially for patients without other risk factors, is to focus more strongly on a guideline-based approach to prescribing medication for CHD patients.

Keywords: Ambulante Versorgung; Cardiovascular disease; Healthcare inequalities; Inanspruchnahme; Kardiovaskuläre Erkrankungen; Outpatient care; Secondary analysis; Sekundäranalyse; Social risk factors; Soziale Risikofaktoren; Utilization; Versorgungsungleichheiten.

MeSH terms

  • Coronary Disease* / drug therapy
  • Cross-Sectional Studies
  • Delivery of Health Care
  • Female
  • Germany
  • Healthcare Disparities*
  • Humans
  • Male
  • Risk Factors
  • Socioeconomic Factors